175 related articles for article (PubMed ID: 22743088)
1. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues.
Roman BI; Ryck TD; Dierickx L; Vanhoecke BW; Katritzky AR; Bracke M; Stevens CV
Bioorg Med Chem; 2012 Aug; 20(15):4812-9. PubMed ID: 22743088
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and structure-activity relationships of some novel, highly potent anti-invasive (E)- and (Z)-stilbenes.
Roman BI; De Coen LM; Thérèse F C Mortier S; De Ryck T; Vanhoecke BW; Katritzky AR; Bracke ME; Stevens CV
Bioorg Med Chem; 2013 Sep; 21(17):5054-63. PubMed ID: 23867387
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
5. Conformationally restricted anti-plasmodial chalcones.
Larsen M; Kromann H; Kharazmi A; Nielsen SF
Bioorg Med Chem Lett; 2005 Nov; 15(21):4858-61. PubMed ID: 16153842
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
7. Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
Roman BI; De Ryck T; Verhasselt S; Bracke ME; Stevens CV
Bioorg Med Chem Lett; 2015 Mar; 25(5):1021-5. PubMed ID: 25666820
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
Zhou J; Geng G; Batist G; Wu JH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1183-6. PubMed ID: 19138519
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and cytotoxicity of a new series of isoxazolidines derived from substituted chalcones.
Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE
Eur J Med Chem; 2011 Apr; 46(4):1382-9. PubMed ID: 21334117
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new amino acids structurally related to the antitumor agent acivicin.
Conti P; Roda G; Stabile H; Vanoni MA; Curti B; De Amici M
Farmaco; 2003 Sep; 58(9):683-90. PubMed ID: 13679161
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
